Pediatrix Medical Group (MD) to Release Earnings on Tuesday

Pediatrix Medical Group (NYSE:MDGet Free Report) is set to announce its earnings results before the market opens on Tuesday, February 20th. Analysts expect the company to announce earnings of $0.30 per share for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link.

Pediatrix Medical Group Stock Up 2.4 %

Shares of NYSE:MD opened at $9.29 on Tuesday. The stock has a fifty day simple moving average of $9.40 and a two-hundred day simple moving average of $11.21. The stock has a market capitalization of $780.13 million, a price-to-earnings ratio of 8.22, a PEG ratio of 0.78 and a beta of 1.57. Pediatrix Medical Group has a 12-month low of $8.18 and a 12-month high of $17.30. The company has a current ratio of 1.20, a quick ratio of 1.20 and a debt-to-equity ratio of 0.64.

Analyst Upgrades and Downgrades

Separately, UBS Group started coverage on Pediatrix Medical Group in a research note on Thursday, November 30th. They set a “neutral” rating and a $9.50 price objective for the company.

Read Our Latest Report on MD

Insiders Place Their Bets

In other Pediatrix Medical Group news, CEO James D. Swift sold 5,764 shares of Pediatrix Medical Group stock in a transaction on Thursday, December 14th. The stock was sold at an average price of $9.58, for a total value of $55,219.12. Following the completion of the sale, the chief executive officer now owns 90,874 shares of the company’s stock, valued at approximately $870,572.92. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 2.00% of the company’s stock.

Institutional Trading of Pediatrix Medical Group

Several large investors have recently modified their holdings of the company. Wells Fargo & Company MN grew its holdings in shares of Pediatrix Medical Group by 0.3% in the second quarter. Wells Fargo & Company MN now owns 251,294 shares of the company’s stock worth $3,571,000 after acquiring an additional 714 shares during the period. Eagle Bay Advisors LLC grew its holdings in shares of Pediatrix Medical Group by 122.5% in the second quarter. Eagle Bay Advisors LLC now owns 1,595 shares of the company’s stock worth $34,000 after acquiring an additional 878 shares during the period. Bank of America Corp DE lifted its position in Pediatrix Medical Group by 0.3% during the first quarter. Bank of America Corp DE now owns 278,204 shares of the company’s stock valued at $6,532,000 after purchasing an additional 933 shares in the last quarter. Cubist Systematic Strategies LLC lifted its position in Pediatrix Medical Group by 3.9% during the third quarter. Cubist Systematic Strategies LLC now owns 26,562 shares of the company’s stock valued at $439,000 after purchasing an additional 1,008 shares in the last quarter. Finally, Royal Bank of Canada lifted its position in Pediatrix Medical Group by 97.3% during the third quarter. Royal Bank of Canada now owns 2,166 shares of the company’s stock valued at $35,000 after purchasing an additional 1,068 shares in the last quarter. Institutional investors own 96.89% of the company’s stock.

About Pediatrix Medical Group

(Get Free Report)

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

Featured Stories

Earnings History for Pediatrix Medical Group (NYSE:MD)

Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.